NCT05632120

Brief Summary

This cross-sectional study aims to investigate to the impairments in body functions and structures, activities and participation restrictions according to the International Classification of Functioning, Disability and Health (ICF) framework in Chronic Obstructive Pulmonary Diseases (COPD) patients.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Dec 2022

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 20, 2022

Completed
10 days until next milestone

First Posted

Study publicly available on registry

November 30, 2022

Completed
5 days until next milestone

Study Start

First participant enrolled

December 5, 2022

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 25, 2023

Completed
2.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

March 30, 2025

Completed
Last Updated

January 30, 2025

Status Verified

June 1, 2024

Enrollment Period

3 months

First QC Date

November 20, 2022

Last Update Submit

January 28, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Activities-Specific Balance Confidence scale

    Activities-Specific Balance Confidence (ABC) scale will be used for evaluating the confidence in maintaining the balance in activities daily living. It provides information on the level of concern about falls during16 community-based and home-based activities. Scale scores between 0 (unsafe) to 100 (completely safe) and the total score (0-1600) is divided by 16 to obtain an individual's ABC score, with higher scores indicating greater balance confidence. In patients with COPD, the ABC scale has demonstrated construct validity as well as criterion validity for falls. In addition, the participants will be also questioned concerning the occurrence of falls and the risk of falling during the activity in each item of the ABC scale.

    Baseline

Secondary Outcomes (5)

  • London Chest Activity of Daily Living scale

    Baseline

  • The COPD Assessment Test

    Baseline

  • The strength of quadriceps femoris

    Baseline

  • The Modified Medical Research Council Dyspnea scale

    Baseline

  • Six-Minute Walking Test (6MWT)

    Baseline

Eligibility Criteria

Age35 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All participants will be patients with COPD diagnosed according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines were recruited from Istanbul University, Department of Chest Diseases.

You may qualify if:

  • stable disease (no severe exacerbations in the prior 3 months)
  • ability to walk independently
  • ability to read and write in Turkish
  • able to follow simple instructions
  • no pathology in visual ability and hearing

You may not qualify if:

  • a history of specific balance problems (i.e., diagnosed vestibular or neurological disorder)
  • severe musculoskeletal, neurological or cardiovascular disorders that limit mobility
  • use of medication(s) that may increase the risk of falls
  • participate in pulmonary rehabilitation in the lasts six months

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Istanbul University

Istanbul, Fatih/İstanbul, 34452, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Pulmonary Disease, Chronic ObstructiveMotor ActivityPatient Participation

Condition Hierarchy (Ancestors)

Lung Diseases, ObstructiveLung DiseasesRespiratory Tract DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsBehaviorPatient Acceptance of Health CareTreatment Adherence and ComplianceHealth Behavior

Study Officials

  • Tansu Birinci, PT, PhD

    Istanbul University - Cerrahpasa

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

November 20, 2022

First Posted

November 30, 2022

Study Start

December 5, 2022

Primary Completion

February 25, 2023

Study Completion

March 30, 2025

Last Updated

January 30, 2025

Record last verified: 2024-06

Data Sharing

IPD Sharing
Will not share

Locations